Search research articles
Contact Us
Filters
Showing results (481-490 of 563) with videos related to
Page
of 57
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
June 15, 1992
Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event
E De Clercq, N Yamamoto, R Pauwels, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
October 21, 2003
Metabolic and pharmacological characteristics of the bicyclic nucleoside analogues (BCNAs) as highly selective inhibitors of varicella-zoster virus (VZV)
R Sienaert, L Naesens, A Brancale, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
December 11, 2007
Synthesis and biophysical characterization of G-rich oligonucleotides conjugated with sugar-phosphate tails
J D'Onofrio, E Erra, G Di Fabio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 1, 1994
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC)
R Snoeck, G Andrei, M Gérard, et al.
Journal of Medicinal Chemistry
|
December 2, 1999
Potent and selective inhibition of varicella-zoster virus (VZV) by nucleoside analogues with an unusual bicyclic base
C McGuigan, C J Yarnold, G Jones, et al.
Antimicrobial Agents and Chemotherapy
|
December 22, 1999
Activities of masked 2',3'-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophages
S Aquaro, O Wedgwood, C Yarnold, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1994
Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100
E De Clercq, N Yamamoto, R Pauwels, et al.
The Journal of Biological Chemistry
|
November 25, 1993
Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis
J Balzarini, A Karlsson, L Wang, et al.
Journal of Medicinal Chemistry
|
August 16, 1996
Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2
N Kolocouris, A Kolocouris, G B Foscolos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma
K Spaepen, S Stroobants, P Dupont, et al.
Page
of 57
Search research articles
Search
Showing results (481-490 of 563) with videos related to
Sort By:
Page
of 57
Proceedings of the National Academy of Sciences of the United States of America
|
June 15, 1992
Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event
E De Clercq, N Yamamoto, R Pauwels, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
October 21, 2003
Metabolic and pharmacological characteristics of the bicyclic nucleoside analogues (BCNAs) as highly selective inhibitors of varicella-zoster virus (VZV)
R Sienaert, L Naesens, A Brancale, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
December 11, 2007
Synthesis and biophysical characterization of G-rich oligonucleotides conjugated with sugar-phosphate tails
J D'Onofrio, E Erra, G Di Fabio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 1, 1994
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC)
R Snoeck, G Andrei, M Gérard, et al.
Journal of Medicinal Chemistry
|
December 2, 1999
Potent and selective inhibition of varicella-zoster virus (VZV) by nucleoside analogues with an unusual bicyclic base
C McGuigan, C J Yarnold, G Jones, et al.
Antimicrobial Agents and Chemotherapy
|
December 22, 1999
Activities of masked 2',3'-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophages
S Aquaro, O Wedgwood, C Yarnold, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1994
Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100
E De Clercq, N Yamamoto, R Pauwels, et al.
The Journal of Biological Chemistry
|
November 25, 1993
Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis
J Balzarini, A Karlsson, L Wang, et al.
Journal of Medicinal Chemistry
|
August 16, 1996
Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2
N Kolocouris, A Kolocouris, G B Foscolos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2002
Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma
K Spaepen, S Stroobants, P Dupont, et al.
Page
of 57